What is a comprehensive approach to pain management for a new nurse practitioner to follow for patients with varying levels of pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pain Management for New Nurse Practitioners

Begin analgesic management immediately when pain is identified—do not delay treatment while pursuing diagnostic workup. 1

Core Assessment Principles

Use the patient's self-report as the primary pain assessment tool, recognizing that pediatric patients, elderly, and cognitively impaired individuals are at highest risk for inadequate pain management. 1 A biopsychosocial assessment is essential—purely biomedical approaches are insufficient. 2

Key Assessment Components:

  • Pain intensity using validated scales 1
  • Functional impact on activities of daily living 2
  • Psychosocial factors including depression, anxiety, fear, and sleep disturbance 3
  • Cultural differences in pain expression must be acknowledged 1
  • Risk stratification using validated tools to identify patients at risk for chronic pain 2

Critical Pain Classifications:

  • Acute pain: 0-7 days duration, typically from trauma, surgery, or acute medical disorder 1
  • Acute exacerbation of recurring condition: Variable duration 1
  • Chronic/persistent pain: Requires different management approach with emphasis on function 1

Pharmacologic Management Algorithm

Step 1: Immediate Analgesic Initiation

Start analgesics as soon as pain is identified—diagnosis should not delay administration. 1

For opioid-naive patients with moderate-severe acute pain:

  • Initiate oxycodone 5-15 mg every 4-6 hours as needed 4
  • For chronic pain, administer around-the-clock rather than as-needed to prevent pain recurrence 4
  • Monitor closely for respiratory depression, especially within first 24-72 hours 4

For mild-moderate pain:

  • Begin with acetaminophen or NSAIDs 1
  • NSAIDs require proton pump inhibitors to reduce gastrointestinal side effects 1
  • Exercise caution with NSAIDs in patients >60 years, compromised fluid status, renal insufficiency, or concurrent nephrotoxic drugs 1

Step 2: Adjuvant Medications for Specific Pain Types

For neuropathic pain resistant to opioids:

  • Tricyclic antidepressants 1
  • Anticonvulsant drugs 1
  • These are particularly important as opioids alone are often inadequate 1

Step 3: Monitoring and Titration

Use the "Four A's" approach for ongoing assessment: 2

  • Analgesia (pain relief achieved)
  • Activities of daily living (functional improvement)
  • Adverse effects (side effects monitoring)
  • Aberrant drug-taking behaviors (addiction screening)

Discontinue analgesic trials if little or no response occurs. 2 For patients on stable doses of strong opioids, monitor at least every six months. 2

Non-Pharmacologic Interventions

Integrate non-pharmacologic modalities from the start—these are adjuncts, not substitutes, for pharmacologic management. 5

Physical Modalities:

  • Physical therapy to improve function and reduce disability 2
  • Massage therapy 1, 6
  • Heat or cold application 1, 7
  • Acupuncture for specific pain syndromes 6

Cognitive-Behavioral Interventions:

  • Cognitive behavioral therapy to address maladaptive thoughts and pain behaviors 2
  • Relaxation techniques using patient's own peaceful memories 7
  • Distraction techniques, especially humor 7
  • Breathing exercises and imagery/hypnosis 1

Patient Education and Self-Management:

  • Provide individualized pain treatment plans at the end of each visit with medication-specific safety considerations 1
  • Patient education has significant impact on pain relief 1
  • Skills training for deep muscle relaxation and proper analgesic use 1

Special Populations and Situations

Patients with Substance Use Concerns:

Critical distinction: Aberrant behaviors do not equate with addiction and may indicate under-treatment of pain. 1

Understand key definitions: 1

  • Tolerance: Adaptation requiring higher doses for same effect
  • Physical dependence: Withdrawal symptoms with abrupt cessation
  • Addiction: Impaired control, compulsive use, continued use despite harm
  • Pseudoaddiction: Drug-seeking behaviors that resolve with adequate pain treatment

Management approach:

  • All patients should be treated appropriately for pain reports, including those with addictive disease 1
  • Provide brief intervention and referral for substance abuse treatment when indicated 1
  • Establish care plans with primary care physicians and analgesic contracts for chronic pain 1

When to Refer to Specialty Services:

Refer when pain is likely to be relieved by consultation or when intervention will restore daily function. 1

Specific indications: 1

  • Inadequate pain control despite pharmacologic therapy
  • Intolerable side effects preventing opioid titration
  • Well-localized pain syndromes amenable to interventional procedures
  • Patient preference for interventional over chronic medication regimen

Protocol Development and Documentation

Develop and adopt analgesic protocols that are physician/nurse developed and nurse-initiated. 1 Measurement of patient response is required by accrediting agencies. 1

Ensure both pharmacologic agents and non-pharmacologic interventions are readily available in your practice setting. 1

Common Pitfalls to Avoid

Do not delay analgesia for diagnostic workup—this is the most critical error. 1

Do not overlook psychosocial factors—failure to address these leads to poor treatment outcomes. 2

Do not assume drug-seeking behavior equals addiction—this may represent pseudoaddiction from inadequate pain treatment. 1

Do not rely solely on imaging and diagnostic tests without considering biopsychosocial factors. 2

Do not prescribe NSAIDs without gastroprotection in at-risk patients. 1

Do not fail to monitor analgesic effectiveness and side effects—inadequate monitoring leads to medication misuse. 2

Tapering Opioids When Appropriate

When discontinuing opioids, taper by no greater than 10-25% of total daily dose to avoid withdrawal symptoms, proceeding at 2-4 week intervals. 8 Ensure multimodal pain management including mental health support is in place before initiating taper. 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pain Pathway and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nonpharmacologic treatment of pain.

Critical care nursing clinics of North America, 2001

Research

Nursing approaches to nonpharmacological pain control.

International journal of nursing studies, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.